Evidence map›Paper›PMID 39033234›Full record

ArticleBone marrow transplantation2024

Assessment of Cytomegalovirus DNA doubling time and virus-specific T-cell responses in the management of CMV infection in allogeneic hematopoietic stem cell transplant recipients undergoing Letermovir prophylaxis.

Marina Esteve, Eliseo Albert, Estela Giménez, Ester Colomer, Juan Carlos Hernández-Boluda, Rafael Hernani, José Luis Piñana, Carlos Solano, David Navarro

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marina EsteveMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Eliseo AlbertMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Estela GiménezMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Ester ColomerMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
Juan Carlos Hernández-BoludaHematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0002-4289-3113
Rafael HernaniHematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
José Luis PiñanaHematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0001-8533-2562
Carlos SolanoHematology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0003-3702-0817
David NavarroMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain. david.navarro@uv.es.ORCID http://orcid.org/0000-0003-3010-4110

Funding

Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) JR20/00011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetatesCytomegalovirusCytomegalovirus InfectionsDNA, ViralHematopoietic Stem Cell TransplantationQuinazolinesAdultAgedAllograftsAntiviral AgentsFemaleHumansMaleMiddle AgedT-LymphocytesTransplantation, HomologousAcetatesAntiviral AgentsDNA, ViralletermovirQuinazolines

Identifiers

PMID39033234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.